Thousand Oaks, CA-based biotechnology company Amgen has selected IPG Mediabrands to handle its U.S. media agency assignments after a formal review that began earlier this year.  

Incumbents included Omnicom and WPP. 

Spending on U.S. media is estimated at $289 million, according to agency research firm COMvergence.  

Amgen issued a brief statement: “After a four-month RFP process, we have awarded our US media business to IPG Mediabrands. We look forward to partnering with IPG Mediabrands which was selected for its best-in-class capabilities and strong talent.” 

Amgen has acquired several companies over the yeas including Horizon Therapeutics, deCODE Genetics, Micromet Inc., and Onyx Pharmaceuticals.   

Amgen retained MediaLink to assist with the review process.